Status:
COMPLETED
Expression of PARP-1 in Multiple Sclerosis Patients
Lead Sponsor:
Sohag University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
This study will explore the expression of PARP-1 in optic neuritis of multiple sclerosis patients. The data will be collected from Sohag University hospital in the period from the start of August 202...
Eligibility Criteria
Inclusion
- Patients with multiple sclerosis with or without optic neuritis Multiple sclerosis will be diagnosed according to the McDonald criteria
Exclusion
- • Isolated optic neuritis.
Key Trial Info
Start Date :
August 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05196425
Start Date
August 1 2021
End Date
April 30 2022
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elshimaa A.Mateen
Sohag, Egypt, 82511